DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF DASATINIB USING SODIUM STARCH GLYCOLATE AS SUPER DISINTEGRANTS
Abstract
The present study was undertaken to develop immediate release (IR) tablets of Dasatinib a selective tyrokinase inhibitor (TKI) which is used in treatment of chronic myeloid leukaemia (CML) and acute myeloid leukaemia (AML).The tablets were prepared by wet granulation method using various excipients, drug and super disintigrants such as sodium starch glycolate(SSG). The prepared tablets were evaluated for pre compression parameters, post compression parameters, in vitro drug release study and stability study. Among the prepared formulations F5 Batch shows 91.32% drug release in 45minutes.The best formulation F5 batch indicates no significant changes from short term stability studies(at 40±2ºC/75±5% RH).Fourier Transform Infrared spectroscopy(FTIR) confirms no drug excipients interaction from various batches.Keywords:  Dasatinib, immediate release tablets, SSG, FTIR Spectroscopy.ÂReferences
Lachman L, liberman HA, Kanig JL.(1990). The theory and practice of industrial pharmacy. 3rd ed.,tablets, 293-335.
Ahmed JA (2015). A Review on immediate release tablet dosage form. Int.J. of Pharmacy and Pharmaceutical Reasearch. 2 (3):1-17.
Wei G, Rafiyath S,Liu D(2010). First-line treatment for chronic myloid leukemia: dasatinib, nilotinib, or imatinib. J. Hematology & Oncology. 3(47):1-10.
Araujo JC, Poblenz A,Corn P, Parikh NU, Starbuck MW, Thompson JT, Francis Lee, Logothetis CJ, Darnay BG.(2009) Dasatinib inhibits both osteoclast activation and prostate cancer PC-3 cell-induced osteoclast formation. Cancer Biology & Therapy. 8 (22): 2009, 2151-2157.
Eiring AM, Khorashad JS, Kimberly Morley, Deininger MW.(2011).Advances in the treatment of chronic myeloid Leukemia. BMC medicine.,9 (99): 1741-7015.
Srinivas P, Mahalaxmi R.(2011).Preparation and invitro evaluation of nizatidine immediate release tablets. Int. J. Pharmtech Res.3(3): 1688-1692.
Sahoo CK, Sahoo NK,Sahu M, Moharana AK, Sarangi DK(2016). Formulation and Evaluation of Orodispersible Tablets of Granisetron Hydrochloride Using Agar as Natural Super disintegrants. Pharm Methods.7(1): 17-22
Yeole CN, Darekar SS, Amit Gupta, Ganga Shrinivasan.(2010). Formulation and Evaluation of Immediate Release Tablet of Paroxetine Hydrochloride.J Phar Res. 3(8): 1736-1738.
Sahoo CK, Sahoo TK, Moharana AK (2011). Designing of orodispersible tablet of diethyl carbamazine citrate for the treatment of filariasis.Inter J Appl Biol Pharm Tech. 2:70-74.
Tiwari AK, Shah A, Rajpoot A, Manmohan Singhal(2011). Formulation and In-vitro Evaluation of Immediate release tablets of Drotaverine HCl. J. Chem. Pharm. Res. 3(4):333-341
Sahoo CK, Rao SRM, Sudhakar M (2015)Evaluation of controlled porosity osmotic pump tablets: A Review. Research J. Pharm. and Tech. 8(12): 1340-1346.
Sahoo CK,Sahoo NK, Rao SRM,Sudhakar M,Satyanarayana K(2015) A review on controlled porosity osmotic pump tablets and its evaluation. Bulletin of Faculty of Pharmacy, Cairo University 53 (2):195-205
Rai VK, Pathak N, Bhaskar R, Nandi BC, Dey S, Tyagi LK(2009). Optimization of immediate release tablet of Raloxifene hydrochloride by wet granulation method. Int. J. Pharm Sci and drug Res. 1(1): 2009, 51-54.
